QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 543 in last 24h · 103,602 total before filter · latest 10m ago
543last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: GSSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Coupang (CPNG) Stock Fair Value Edges Lower After Analysts Rework Earnings
Simply Wall St.17h agoneutral
Coupang (CPNG) Stock Fair Value Edges Lower After Analysts Rework Earnings

Coupang’s fair value estimate has shifted slightly from US$26.29 to US$25.83, mirroring modest cuts in analyst price targets. The change ties back to recent research where analysts are reworking models for tax and regulatory developments, currency effects and updated earnings assumptions that influence how confident they feel about Coupang’s medium term profile. As you read on, you will see how these price target tweaks fit into the broader bull and bear narrative and what to watch as that...

Bloomberg2d agoneutral
Morgan Stanley’s Wilson Tips Earnings to Revive Momentum Trade

(Bloomberg) -- Momentum-style equity investing is poised to rebound from a sharp retreat as sectors with strong earnings replace chip stocks in leading the market’s gains, Morgan Stanley strategist Michael Wilson said.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosSingapore's Gated Island for the Rich Is Marred by Decayed HomesTrump Says Iran Talks to Begin Monday After Scrapping AttackCrushed by Kospi Rout,

Goldman Sachs uncovers key AbbVie stock signals before earnings
TheStreet7d agoneutral
Goldman Sachs uncovers key AbbVie stock signals before earnings

AbbVie(ABBV) reports second-quarter results on Friday, July 31, and the mood around the stock has changed. A few months ago, investors were restless. The two drugs carrying the company were doing fine, but everyone already knew that, and the market wanted a new reason to invest. Goldman Sachs went ...

The Bull Case For Goldman Sachs Group (GS) Could Change Following Record Q2 Earnings And Bigger Buybacks
Simply Wall St.13d agobullish
The Bull Case For Goldman Sachs Group (GS) Could Change Following Record Q2 Earnings And Bigger Buybacks

Earlier in July 2026, Goldman Sachs reported strong second-quarter results, with net income rising to US$6.63 billion and earnings per share roughly doubling year-on-year. Alongside these results, Goldman Sachs intensified capital return and funding actions, including billions in new bond and preferred issuances plus continued buybacks and a higher quarterly dividend. We’ll now examine how this combination of record earnings and increased capital returns might influence Goldman Sachs’...

Elon Musk's Tesla Releases Wall Street Estimates Ahead of Q2 Earnings: Here's What Analysts Expect
Benzinga16d agoneutral
Elon Musk's Tesla Releases Wall Street Estimates Ahead of Q2 Earnings: Here's What Analysts Expect

Tesla Inc. (NASDAQ:TSLA) released its company-compiled data of sell-side analysts’ forecasts for the automaker’s second-quarter 2026 earnings estimates ahead of this week’s earnings call. Analysts Predict $27 Billion in Revenue On Saturday, the Elon Musk-led automaker announced earnings forecasts from analysts at JP Morgan Chase & Co. (NYSE:JPM), Goldman Sachs Group Inc. (NYSE:GS) and several others. Read Also: This Week in Tesla: Elon Musk Faces Pay Package Questions, US EV Prices Fall and More

Banks’ Blowout Earnings Steal the Spotlight from Big Tech—for Now
Barrons.com20d agoneutral
Banks’ Blowout Earnings Steal the Spotlight from Big Tech—for Now

Wall Street cleared this earnings season’s first major hurdle with room to spare, as the nation’s biggest banks pummeled profit forecasts. “Bank earnings are often described as a scoreboard for the financial sector,” said Ruben Dalfovo, investment strategist at Saxo Bank. “They are more useful as an economic medical examination, and the early numbers suggest the patient remains active, and dealmaking appears healthier.”

Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.
Barrons.com21d agobearish
Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.

Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.

The Goldman Sachs Group Q2 Earnings Call Highlights
MarketBeat22d agoneutral
The Goldman Sachs Group Q2 Earnings Call Highlights

The Goldman Sachs Group (NYSE:GS) reported record second-quarter 2026 results, with Chairman and Chief Executive Officer David Solomon citing strong client activity, an acceleration in strategic dealmaking and rising demand tied to artificial intelligence infrastructure investment. Goldman generate

Goldman Shares Eye Record Close Following Blowout Earnings
Barrons.com22d agoneutral
Goldman Shares Eye Record Close Following Blowout Earnings

Goldman shares were on pace to close at a new high, with shares on Tuesday morning rising 8.6% to $1,136.15 a share--an intraday high--following a record set of second quarter earnings that blew past Wall Street forecasts. The bank posted a record $7.42 billion in stock trading, topping Wall Street’s $5 billion estimate by nearly 50%, as well as $3.4 billion in investment banking fees and $4.59 billion in interest rate trading. Group profits for the three months ending in June were pegged at $20.98 a share, a staggering 92% increase from the same period last year, smashing Wall Street’s forecast of $14.38 a share forecast.